Get our introductory offer at only
$0
.99*/month
Cancel anytime
*$0.99/month for first 3 months
$29.90/month for the next 9 months
You are here
How Singapore can lead biopharma innovation
The Republic needs to align its patent term extension regime with international standards, and so start attracting more clinical trials.
For pharmaceutical companies, patents are the primary way to offset the high R&D costs that can stretch over decades, and ensure sustainable investment into the medicines of tomorrow.
BT PHOTO: KUA CHEE SIONG
SINGAPORE is known by the global innovation and intellectual property (IP) expert community as a leader in the protection of IP rights. The latest International Property Rights Index for 2019 again listed Singapore as having Asia's strongest protection of intellectual property (IP) rights;...
Please log in to continue reading.
